This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Molina Healthcare (MOH) Receives a Buy from Bernstein

Tipranks - Tipranks - Thu May 28, 6:36AM CDT

Bernstein analyst maintained a Buy rating on Molina Healthcare today and set a price target of $208.00.

Memorial Day Sale – Claim 70% Off TipRanks

In addition to Bernstein, Molina Healthcare also received a Buy from Bank of America Securities’s Kevin Fischbeck in a report issued on May 11. However, yesterday, Barclays maintained a Sell rating on Molina Healthcare (NYSE: MOH).

See today’s best-performing stocks on TipRanks >>

Based on Molina Healthcare’s latest earnings release for the quarter ending March 31, the company reported a quarterly revenue of $10.8 billion and a net profit of $14 million. In comparison, last year the company earned a revenue of $11.15 billion and had a net profit of $298 million

Based on the recent corporate insider activity of 58 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of MOH in relation to earlier this year. Earlier this month, Maurice Hebert, the CAO of MOH sold 600.00 shares for a total of $114,930.00.

Read More on MOH:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).